5: Allergy and the skin: Eczema nd chronic urticaria

Medical Journal of Australia

Volumn 185, Issue 9, 2006, Pages 517-522

  Katelaris, Constance H ^a   Peake, Jane E ^b  

^a Westmead Medical Centre   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EMOLLIENT AGENT; FISH OIL; FOOD ALLERGEN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; IRRITANT AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PIMECROLIMUS; PRIMROSE OIL; PROBIOTIC AGENT; THYROXINE; TSUKUBAENOLIDE;

ALLERGIC VASCULITIS; ANGIONEUROTIC EDEMA; ARTICLE; AUTOIMMUNITY; CANCER RISK; CHILDHOOD DISEASE; CHRONIC URTICARIA; CLIMATE CHANGE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DAILY LIFE ACTIVITY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE RESISTANCE; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ECZEMA; EGG ALLERGY; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HEALTH EDUCATION; HELICOBACTER INFECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; KIDNEY DISEASE; LOW DRUG DOSE; MEDICAL SPECIALIST; NONHUMAN; PAPULAR URTICARIA; PATIENT REFERRAL; PLASMAPHERESIS; PROGNOSIS; PRURITUS; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SHORT COURSE THERAPY; SKIN ALLERGY; SKIN BURNING SENSATION; SKIN CANCER; SKIN EXAMINATION; SKIN INFECTION; SKIN MANIFESTATION; STRESS; TREATMENT FAILURE; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT;

EID: 33751044043     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00670.x     Document Type: Article

References (38)

1. Paller AS, McAlister RO, Doyle JJ, Jackson A. Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment. Clin Pediatr (Phila) 2002; 41: 323-332.
2. Kusel MM, Holt PG, de Klerk N, Sly PD. Support for 2 variants of eczema. J Allergy Clin Immunol 2005; 116:1067-1072.
3. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Chn Immunol 2004, 113: 832-836.
4. Starke PR, Weaver J, Chowdhury BA. Boxed warning added to promethazine labeling for pediatric use. N Engl J Med 2005; 352: 2653.
5. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4(37). http://www.ncchta.org/ execsumm/summ437.htm (accessed Sep 2006).
6. Atherton DJ. Topical corticosteroids in atopic dermatitis. BMJ 2003; 327: 942-943.
7. Conroy S. New products for eczema. Arch Dis Child Educ Pract Ed 2004; 89: ep23-ep26.
8. Wahn U, Bos JD, Goodfield M, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002; 110 (1 Pt 1): e2.
9. Fonacier L, Spergel J, Charlesworth EN, et al. Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2005; 115:1249-1253.
10. National Health and Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Canberra: NHMRC, 2000. http://www.nhmrc.gov.au/publications/_files/cp69.pdf (accessed Jul 2006).
11. Sampson HA, Scanlon SM. Natural history of food hypersensitivity in children with atopic dermatitis. J Pediatr 1989; 115: 23-27.
12. Sampson HA, McCaskill CC. Food hypersensitivity and atopic dermatitis: evaluation of 113 patients. J Pediatr 1985; 107: 669-675.
13. Lever R, MacDonald C, Waugh P, Aitchison T. Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol 1998; 9: 13-19.
14. Eigenmann PA, Sicherer SH, Borkowski TA, et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101(3): e8.
15. Sampson HA, Albergo R. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 1984; 74: 26-33.
16. Cavagni G, Paganelli R, Caffarelli C, et al. Passage of food antigens into circulation of breast-fed infants with atopic dermatitis. Ann Allergy 1988; 61: 361-365.
17. Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005, 90: 892-897.
18. Isolauri E, Arvola T, Sutas Y, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30: 1604-1610.
19. Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113: 925-931.
20. O'Donnell BF, Lawler F, Simpson J, et al. The impact of chronic urticaria on quality of life. Br J Dermatol 1997; 136: 197-201.
21. Commens CA, Greaves MW. Cimetidine in chronic idiopathic urticaria: a randomised double-blind study. Br J Dermatol 1978; 99: 675-676.
22. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000; 84: 517-522.
23. Di Lorenzo G, Pacor ML, Mansueto P, et al. Randomised placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 2004; 114: 619-625.
24. Paul E. Loratadine and terfenadine in the treatment of chronic urticaria. Allergy 1988; 43 Suppl 7: 122.
25. Charlesworth EN, Massey WA, Kagey-Sobotka A, et al. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992; 262: 964-970.
26. Sanada S, Tanaka T, Kameyoshi Y, Hide M. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria. Arch Dermatol Res 2005; 297: 134-138.
27. Sigurgeirsson B. Skin disease and malignancy: an epidemiological study. Acta Derm Venereol Suppl (Stockh) 1992; 178: 1-110.
28. Doeglas HMG. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 1975; 93: 135-144.
29. Simon RA. Additive-induced urticaria: experience with monosodium glutamate. J Nutr 2000; 130: 1063S-1066S.
30. Wedi B, Wagner S, Werfel T, et al. Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria. Int Arch Allergy Immunol 1998; 116: 288-294.
31. De Koster E, De Bruyne I, Langlet P, Deltenre M. Evidence-based medicine and extradigestive manifestations of Helicobacter pylori. Acta Gastroenterol Belg 2000; 63: 388-392.
32. Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema and thyroid autoimmunity. Arch Dermatol 1983; 119: 636-640.
33. Kikuchi Y, Fann T, Kaplan AP. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol 2003; 112: 218.
34. Rumbyrt JS, Katz JL, Schocket A. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995; 96: 901-905.
35. Alversano M, Caiazzo P, Lorio G, et al. Improvement of chronic urticaria with l-thyroxine: a new TSH role in immune response? Allergy 2005; 60: 489-493.
36. Tong LJ, Balakrishnan G, Kochan JP, et al. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997; 99: 461-465.
37. Reeves GE, Boyle MJ, Bonfield J, et al. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004; 34: 182-186.
38. Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic "idiopathic" urticaria. Br J Dermatol 2000; 143: 365-372.